U.S. Polymerase Chain Reaction Market - Industry Trends and Forecast to 2030

U.S. Polymerase Chain Reaction Market - Industry Trends and Forecast to 2030
U.S. polymerase chain reaction market is expected to reach USD 11,168.47 million by 2030 from USD 4,465.81 million in 2022, growing at a CAGR of 12.2% during the forecast period of 2023 to 2030.

Market Segmentation
By Product Type (Reagents, Instruments, Consumables, Software, and Services), Method (Real-Time PCR, Reverse-Transcriptase (RT) PCR, Conventional PCR, Multiplex PCR, Nested PCR, Hot Start PCR, Long-Range PCR, Assembly PCR, Inverse PCR, and Others), Application (Clinical, Life Science and Related Researches, Forensic Science, Environmental Microbiology and Other), End User (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Forensic Laboratories, Reference Laboratories, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) Country (U.S.) - Industry Trends and Forecast to 2030

Overview of U.S. Polymerase Chain Reaction Market Dynamics

Driver

• Rise in the availability of PCR diagnostics

Restrain

• Limitation analyzing novel complex devices
Opportunity

• Rising research and development activities

Market Players

Some of the key players operating in the U.S. polymerase chain reaction market are
• Beckman Coulter, Inc
• F. Hoffmann-La Roche Ltd
• Promega Corporation
• Illumina, Inc
• Bio-Rad Laboratories, Inc
• QIAGEN
• Merck KGaA
• GenScript
• Thermo Fisher Scientific Inc
• PerkinElmer Inc
• Enzo Life Sciences, Inc.
• bioMérieux Inc
• Takara Bio Inc.
• LGC biosearch technologies
• Meridian bioscience, Inc.,
• luminex corporation
• Agilent Technologies, Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. These report will take approximately 15-20 business days to prepare and deliver.